Augustina Isioma Ikusemoro/LinkedIn
Apr 2, 2026, 04:47
Augustina Isioma Ikusemoro: A Small Antigen with Big Clinical Consequences
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“Know Your Kell: A Small Antigen with Big Clinical Consequences
The Kell antigen system is one of the most clinically significant blood group systems after ABO and Rh, yet it is often under-recognized outside specialist transfusion practice.
This infographic highlights why the K antigen (K1) matters in everyday transfusion medicine:
- The Kell antigen is expressed on red blood cells and can trigger clinically significant alloimmunization
- Anti-K antibodies are a major cause of Hemolytic Disease of the Fetus and Newborn (HDFN)
- Sensitization commonly occurs after transfusion or pregnancy
- Anti-K is typically IgG reactive at 37°C, capable of crossing the placenta
- Safe transfusion practice requires Kell-negative blood for patients with anti-K antibodies
Understanding Kell compatibility is essential for protecting:
- chronically transfused patients
- women of child-bearing age
- fetuses at risk of HDFN
- patients with previous alloimmunization
Because in transfusion medicine, compatibility goes far beyond ABO and RhD.
Blood Doki — Advancing transfusion safety through education, advocacy, and clinical awareness.”
Stay updated with Hemostasis Today.
-
Oct 6, 2026, 22:43Alessandra Bosch: Pediatric GTH Opens with Regional Experts Convening on Pediatric Hemostasis and Thrombosis
-
Oct 6, 2026, 22:39Managing Thrombotic Risk in Pregnancy – How the Lab May Help – Sysmex Europe
-
Oct 6, 2026, 22:33Ahmet Davut Aksu: A Multi-Objective Approach to Enhance Fibrinolysis, Selectivity, and Inhibition Resistance
-
Oct 6, 2026, 22:29Muhammad Abubakar: New Study on Iron Biology to Be Presented at ASH 2026 and Published in Blood
-
Oct 6, 2026, 22:24David McIntosh: Calling On Decision-Makers to Prioritize Donors and Clinical Access During IPAW 2026
-
Oct 6, 2026, 22:21Zoltan Nagy: With All Eyes on Optogenetics Today, What Can It Do in Megakaryocytes and Platelets?
-
Oct 6, 2026, 22:13Khalid A. Fakhro: Sidra Medicine Hosts RAPID 2026 Advancing Diagnostics and Treatments for Inborn Errors of Immunity
-
Oct 6, 2026, 22:04Denis Oduor: Preparedness for Postpartum Haemorrhage Must Include Preparedness for Blood
-
Oct 6, 2026, 21:57Farhad Moradpour: Health Equity and Public Health – What Drives Anemia Disparities in Ethnic Minority Populations?